THE GOAL OF THE PROPOSED PROJECT IS TO FURTHER DEVELOP ANTAGEN'S NOVEL PROTEIN NANOPARTICLE-BASED EXPRESSION AND DELIVERY SYSTEM USING FCRIDER TECHNOLOGY AND ANTIBODY AFUCOSYLATION TECHNOLOGY TO PRODUCE A2,6-SIALYLATED AFUCOSYLATED ENV-FCRIDER (

DEFINITIVE CONTRACT won by ANTAGEN BIOSCIENCES INC · work in CANTON, MA
$299,998
RecipientANTAGEN BIOSCIENCES INC UEI HXD6EFH2ND57
Award ID75N93022C00011
Award amount$299,998
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSCAN12
Set-asideSmall business
Start dateJul 1, 2022
End dateJun 30, 2023
Place of performanceCANTON, MA
Record updatedFeb 7, 2024

View the official award record

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids